Skip to main content

John Sargent Sundy

Adjunct Professor in the Department of Medicine
Medicine, Rheumatology and Immunology
Duke Box 3278, 3854 Clinic 3N, Duke Clinic, Durham, NC 27710
Gilead Sciences, 333 Lakeside Dr, Foster City, CA 94404

Selected Grants


Interdisciplinary Training Program in Lung Disease

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2009 - 2021

Training Program in Inflammatory and Immunological Diseases

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 1980 - 2017

Clinical Practice Data to Aid Narrow Therapeutic Index Drug Classification

ResearchFaculty Member · Awarded by Food and Drug Administration · 2013 - 2016

Idiopathic Pulmonary Fibrosis Clinical Research Network NCE

Clinical TrialCo Investigator · Awarded by National Institutes of Health · 2005 - 2014

CARRA: Accelerating Toward an Evidence Based Culture in Pediatric Rheumatology

ResearchCo Investigator · Awarded by National Institutes of Health · 2009 - 2013

PEG-uricase as Therapy for Refractory Gout IND#11274

ResearchCo-Principal Investigator · Awarded by Food and Drug Administration · 2004 - 2009

Role of TLR4 in Environmental Asthma

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2001 - 2007

Management of Allergic Rhinitis in the Working-Aged Population

ResearchInvestigator · Awarded by Agency for Healthcare Research and Quality · 2001 - 2003

Mechanisms And Therapy Of Primary Immunodeficiency

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1995 - 1999

Research Training In Allergy And Clinical Immunology

Inst. Training Prgm or CMECo-Principal Investigator · Awarded by National Institutes of Health · 1907 - 1999

External Relationships


  • Gilead Sciences, Inc.
  • Imhotex
  • Neutrolis, Inc
  • Rome Therapeutics
  • Seismic Therapeutic (primary employer)
  • Upstream Biotechnology

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.